Literature DB >> 19186999

Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis.

Achuthan Raghavamenon1, Mahdi Garelnabi, Sainath Babu, Alex Aldrich, Dmitry Litvinov, Sampath Parthasarathy.   

Abstract

The decomposition of peroxidized lipids of low-density lipoprotein (LDL) has been suggested to be involved in atherosclerosis. In this study, an in vitro system with 13-hydroperoxylinoleic acid (13-HPODE) was used to determine the effects of antioxidants on its decomposition. Decomposition of 13-HPODE was not affected by alpha-tocopherol, several other antioxidants, or antioxidant enzymes. Moreover, the inclusion of alpha-tocopherol during the decomposition of 13-HPODE resulted in an accumulation of aldehydes. Further oxidation of aldehydes to carboxylic acids by a number of oxidases was prevented by alpha-tocopherol. Conversely, the formation of carboxylic acids may be conducive to plaque stabilization via immunomodulation, rapid degradation, and by calcium sequestration. Thus, the inhibition of formation of carboxylic acids could be a serious deleterious effect of antioxidant treatment. In contrast, alpha-keto acids, like pyruvic acid, promoted the conversion of 13-HPODE to 13-hydroxylinoleic acid (13-HODE) by readily undergoing decarboxylation into acetate. These observations suggest that agents that promote the reduction of lipid peroxides into lipid hydroxides could be far more effective in treating cardiovascular diseases as opposed alpha-tocopherol-like antioxidants that could affect additional steps in the oxidation cascade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186999      PMCID: PMC2842134          DOI: 10.1089/ars.2008.2248

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  50 in total

Review 1.  Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?

Authors:  Kevin Jon Williams; Edward A Fisher
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-03       Impact factor: 4.294

2.  Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Authors:  I-Min Lee; Nancy R Cook; J Michael Gaziano; David Gordon; Paul M Ridker; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

3.  Epoxidation of trans-4-hydroxy-2-nonenal by fatty acid hydroperoxides and hydrogen peroxide.

Authors:  H J Chen; F L Chung
Journal:  Chem Res Toxicol       Date:  1996 Jan-Feb       Impact factor: 3.739

4.  Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase.

Authors:  T B Rajavashisth; J K Liao; Z S Galis; S Tripathi; U Laufs; J Tripathi; N N Chai; X P Xu; S Jovinge; P K Shah; P Libby
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 5.  A clinical overview of azelaic acid.

Authors:  Boni Elewski; Diane Thiboutot
Journal:  Cutis       Date:  2006-02

6.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Authors:  Eva Lonn; Jackie Bosch; Salim Yusuf; Patrick Sheridan; Janice Pogue; J Malcolm O Arnold; Catherine Ross; Andrew Arnold; Peter Sleight; Jeffrey Probstfield; Gilles R Dagenais
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

7.  Synthesis of dihydroperoxides of linoleic and linolenic acids and studies on their transformation to 4-hydroperoxynonenal.

Authors:  Claus Schneider; William E Boeglin; Huiyong Yin; Donald F Ste; David L Hachey; Ned A Porter; Alan R Brash
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

8.  Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.

Authors:  C Napoli; C K Glass; J L Witztum; R Deutsch; F P D'Armiento; W Palinski
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

9.  Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.

Authors:  T B Rajavashisth; X P Xu; S Jovinge; S Meisel; X O Xu; N N Chai; M C Fishbein; S Kaul; B Cercek; B Sharifi; P K Shah
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

10.  alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity.

Authors:  K A Nath; E O Ngo; R P Hebbel; A J Croatt; B Zhou; L M Nutter
Journal:  Am J Physiol       Date:  1995-01
View more
  13 in total

Review 1.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

2.  Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Kuikwon Kim; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2010-03-10       Impact factor: 5.162

3.  Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.

Authors:  Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi; Larissa Brophy; Sampath Parthasarathy
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

4.  A Novel Mechanism for Atherosclerotic Calcification: Potential Resolution of the Oxidation Paradox.

Authors:  Aladdin Riad; Chandrakala Aluganti Narasimhulu; Pragney Deme; Sampath Parthasarathy
Journal:  Antioxid Redox Signal       Date:  2018-01-24       Impact factor: 8.401

5.  Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers.

Authors:  M Garelnabi; E Veledar; J White-Welkley; N Santanam; J Abramson; W Weintraub; S Parthasarathy
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-07-22       Impact factor: 4.222

6.  Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Authors:  Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  Methods Mol Biol       Date:  2022

7.  Characterization of fecal metabolome changes in patients with obstructive sleep apnea.

Authors:  Ying Dong; Pan Wang; Junling Lin; Chunming Han; Jie Jiao; Kun Zuo; Mulei Chen; Xinchun Yang; Jun Cai; He Jiang; Xiheng Guo; Jing Li
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

8.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20

Review 9.  Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-20

10.  Differential lipid metabolism in monocytes and macrophages: influence of cholesterol loading.

Authors:  Irene Fernandez-Ruiz; Patrycja Puchalska; Chandrakala Aluganti Narasimhulu; Bhaswati Sengupta; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2016-02-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.